about
FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt.DNMT3B promoter polymorphism and risk of immune thrombocytopenic purpura in pediatric Egyptians.Detection of expression of IL-18 and its binding protein in Egyptian pediatric immune thrombocytopenic purpura.Blood transfusion among thalassemia patients: A single Egyptian center experienceDetection of trisomy 4 and 10 in Egyptian pediatric patients with acute lymphoblastic leukemia.Peripheral expression of hepcidin gene in Egyptian β-thalassemia major.A localized case-control study of extra-gastric manifestations of Helicobacter pylori infection in children.Apolipoprotein E gene polymorphism and the risk of left ventricular dysfunction among Egyptian β-thalassemia major.Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.Methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in chronic myeloid leukemia: an Egyptian study.Quantitative assessment of Wilms tumor 1 (WT1) gene transcripts in Egyptian acute lymphoblastic leukemia patients.Detection of orphan receptor tyrosine kinase (ROR-1) expression in Egyptian pediatric acute lymphoblastic leukemia.Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, and GSTP1) in Egyptian pediatric patients with sickle cell disease.Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion.Vitamin D Insufficiency is Not Associated With Pediatric and Adolescent Immune Thrombocytopenia: A Study in Conjunction With its Receptor Genetic PolymorphismsThe prevalence of combined vascular endothelial growth factor, endothelial nitric oxide synthase and thrombin-activatable fibrinolysis inhibitor genetic polymorphisms among Egyptian patients with recurrent spontaneous abortionL-Selectin P213S and Integrin Alpha 2 C807T Genetic Polymorphisms in Pediatric Sickle Cell Disease Patients
P50
Q33398468-E8B16615-CECB-4082-B304-D553FC70B04EQ33402776-93156C92-376E-4F7B-B9DF-7B423FF479B8Q33406842-936A2582-445F-4D7C-A696-D8DBE568EA51Q36732667-43B089BF-11A5-49A0-9011-C880199EF1F1Q38420949-8944D75F-0588-4E79-AB6E-287BEC93C022Q38857914-DF12B12B-390C-4A3F-A989-43DC8581581CQ38861659-86065C3C-3769-49BB-83CC-6EA67BC63F66Q38990141-3985AC5F-D1C3-41B0-A9DC-B82D2F18EFE9Q39030042-214E2097-FBF9-46B0-9957-F8FCA702F694Q39134483-06A0565C-B56F-4063-9715-44072CB639E3Q39418893-EEC395BE-9944-42BA-B6DF-FE13ADBA6BF0Q39449973-201EE0AD-71D2-400D-BD66-69E63E988A2AQ39457026-2523FA5A-14AB-4F4D-B8AC-F7F5E9D2BB95Q46946811-CB4973C7-EFB5-464C-97C6-F5AB74C09907Q91897871-4875132E-0401-4AFB-A34D-A1F04A1A5180Q92992605-E1708BB1-7DEB-430E-9410-3C0E06C5F6FCQ95318524-BDD3234B-5675-40C3-A46E-32C9FE6BBE42
P50
description
researcher ORCID ID = 0000-0002-5525-9250
@en
wetenschapper
@nl
name
Iman A Shaheen
@ast
Iman A Shaheen
@en
Iman A Shaheen
@es
Iman A Shaheen
@nl
type
label
Iman A Shaheen
@ast
Iman A Shaheen
@en
Iman A Shaheen
@es
Iman A Shaheen
@nl
prefLabel
Iman A Shaheen
@ast
Iman A Shaheen
@en
Iman A Shaheen
@es
Iman A Shaheen
@nl
P106
P1153
35786395700
P31
P496
0000-0002-5525-9250